Literature DB >> 19741318

Practical management: a systematic approach to the evaluation of exercise-related syncope in athletes.

Francis G O'Connor1, Benjamin D Levine, Marc A Childress, Chad A Asplundh, Ralph G Oriscello.   

Abstract

Syncope and presyncope are relatively common presentations among athletes. The distinction between post-exercise and during-exercise syncope is critically important. While the great majority of these episodes occur just after exercise and are benign, syncope can be an indication of serious underlying cardiovascular disease if it occurs during exercise. Syncope presents a challenging differential diagnosis, as well as a daunting array of diagnostic tests and advanced imaging strategies. Sequencing a proper evaluation, and deciding who requires consultation and restriction, can be difficult for the medical provider. We present a systematic approach that assists the sports physician in arriving at a diagnosis and organizing an initial management strategy.

Entities:  

Mesh:

Year:  2009        PMID: 19741318     DOI: 10.1097/JSM.0b013e3181b732c3

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  3 in total

1.  Postexercise syncope: Wingate syncope test and effective countermeasure.

Authors:  Alisha N Lacewell; Tahisha M Buck; Steven A Romero; John R Halliwill
Journal:  Exp Physiol       Date:  2013-09-27       Impact factor: 2.969

2.  Left ventricle fibrosis associated with nonsustained ventricular tachycardia in an elite athlete: is exercise responsible? A case report.

Authors:  Mathias Poussel; Karim Djaballah; Julien Laroppe; Béatrice Brembilla-Perrot; Pierre-Yves Marie; Bruno Chenuel
Journal:  J Athl Train       Date:  2012 Mar-Apr       Impact factor: 2.860

Review 3.  Blood pressure regulation X: what happens when the muscle pump is lost? Post-exercise hypotension and syncope.

Authors:  John R Halliwill; Dylan C Sieck; Steven A Romero; Tahisha M Buck; Matthew R Ely
Journal:  Eur J Appl Physiol       Date:  2013-11-07       Impact factor: 3.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.